Molecular Mechanism of DNA Topoisomerase I-Dependent rDNA Silencing: Sir2p Recruitment at Ribosomal Genes by D'Alfonso, Anna et al.
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
1 
 
 
Molecular mechanism of DNA topoisomerase I-dependent 
rDNA silencing: Sir2p recruitment at ribosomal genes. 
 
AUTHORS 
Anna D'Alfonso (1), Francesca Di Felice (1), Valentina Carlini (1), Christine M Wright (2), 
Marla I Hertz (2), Mary-Ann Bjornsti (2)* and Giorgio Camilloni, (1, 3)* 
AFFILIATIONS 
(1) Dipartimento di Biologia e Biotecnologie, Università di Roma Sapienza, Roma, 
00185, Italy 
(2) Department of Pharmacology and Toxicology, University of Birmingham at Alabama, 
Birmingham AL, 35294, USA 
(3) Istituto Pasteur, Fondazione Cenci Bolognetti, Università di Roma Sapienza, Roma, 
00185, Italy 
 
Anna D'Alfonso, dalfonsoanna@yahoo.it 
Francesca Di Felice, francesca.difelice@uniroma1.it 
Valentina Carlini, vale611@hotmail.it 
Christine M Wright, cwright7@uab.edu 
Marla I Hertz, marla.hertz@gmail.com 
Mary-Ann Bjornsti, bjornsti@uab.edu 
Giorgio Camilloni, giorgio.camilloni@umiroma1.it 
 
* To whom correspondence should be addressed 
Mary-Ann Bjornsti Tel: +1 2059344579; Email: bjornsti@uab.edu 
Giorgio Camilloni. Tel: +39 0649912808. Fax: +39 0649912500. Email: 
giorgio.camilloni@umiroma1.it 
*Manuscript
Click here to view linked References
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
2 
 
ABSTRACT 
Saccharomyces cerevisiae sir2Δ or top1Δ mutants exhibit similar phenotypes 
involving ribosomal DNA, including; i) loss of transcriptional silencing, resulting in non-
coding (nc)RNA hyper-production from cryptic RNA Polymerase II promoters; ii) 
alterations in recombination; and iii) a general increase in histone acetylation. Given the 
distinct enzymatic activities of Sir2 and Top1 proteins, a histone deacetylase and a DNA 
topoisomerase, respectively, we investigated whether genetic and/or physical 
interactions between the two proteins could explain the shared rDNA phenotypes. We 
employed an approach of complementing top1Δ cells with yeast, human, truncated and 
chimeric yeast/human TOP1 constructs, and assessing the extent of ncRNA silencing 
and histone H4K16 deacetylation. Our findings demonstrate that residues 115-125 
within the yeast Top1p N-terminal domain are required for complementation of the 
top1∆ rDNA phenotypes. In chromatin immunoprecipitation (ChIP) and co-
immunoprecipitation experiments, we further demonstrate the physical interaction 
between Top1p and Sir2p. Our genetic and biochemical studies support a model 
whereby Top1p recruits Sir2p to the rDNA, and clarifies a structural role of DNA 
topoisomerase I in the epigenetic regulation of rDNA, independent of its known catalytic 
activity.  
 
 
 
 
Keywords: DNA topoisomerase I; Sir2p; Transcriptional silencing; histone 
acetylation; rDNA. 
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INTRODUCTION 
In the budding yeast Saccharomyces cerevisiae, the ribosomal RNA genes 
(rDNA) are arrayed in tandem repeats of 150-200 units on chromosome XII (1). Each 
repeated unit is interrupted by an Intergenic Spacer Region (IGS), which contains: i) a 
replication origin (ARS, for autonomous replicating sequence); ii) a promoter of the 35S 
RNA gene that is transcribed by RNA polymerase I (Pol I), iii) the 5S RNA gene 
transcribed by RNA polymerase III (Pol III); and iv) two cryptic non-coding RNA 
promoters (E-pro and C-pro), which are transcribed at low levels by RNA polymerase II 
(Pol II). In addition, each unit includes a replication fork barrier (RFB). Binding of the 
Fob1 protein to RFB sites selectively stalls the movement of replication forks in only 
direction (2). This asymmetric stalling of only one of the bi-directional replication forks at 
Fob1p-bound RFB sites avoids the adverse effects that would otherwise result from 
head-on collisions between the advancing replication machinery and transcription 
bubbles. At RFBs, recombination events also occur that maintain the homogeneity of 
the rDNA units. Dysregulation of these events leads to change in unit copy number 
and/or the formation of extrachromosomal rDNA circles (ERCs) (3).   
The locus of tandem rDNA repeats is a highly active region of the genome at 
which concurrent DNA replication, transcription and recombination occurs (4). 
Consequently, strict control of polynucleotide polymerization and recombination are 
necessary to maintain rDNA stability. In this regard, the epigenetic state of rDNA 
chromatin, in particular the acetylation of histone H4 at residue Lys16 (H4K16) (5), has 
been demonstrated to be crucial for the coordination of these enzymatic functions.  
Sir2p is one of four Silent Information Regulator (SIR) genes in yeast that 
function in transcription silencing. However, Sir2p uniquely posseses NAD+-dependent 
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histone deacetylase activity and is the only SIR gene product to function in the 
nucleolus.  Yeast strains deleted for the SIR2 gene (sir2∆), exhibit several phenotypes 
involving rDNA gene dysregulation, such as the loss of transcriptional silencing (6, 7), 
which results in ncRNA hyper-production from the cryptic Pol II promoters, E-pro and C-
pro (8), and alterations in recombination (9), as evidenced by changes in rDNA unit 
copy number or elevated production of ERCs (10). Furthermore, sir2Δ mutants exhibit a 
general increase in histone acetylation of rDNA chromatin, particularly at H4K12, H4K16 
and H3K9 residues (11). Indeed, the rDNA defects observed in sir2Δ mutants are 
consistent with the loss of Sir2p histone deacetylase activity (12; 13; 14; 15). 
Deletion of the TOP1 gene, which encodes DNA topoisomerase 1 (Top1p), also 
impacts rDNA, and the features of these top1∆ phenotypes almost completely overlap 
those observed in sir2Δ mutants. Notably, rDNA repeat hyper-recombination, loss of 
rDNA transcriptional silencing and the hyperacetylation of histone residues have all 
been reported in top1Δ mutants (16; 17; 18; 19; 20).  The gene products of SIR2 and 
TOP1 represent distinct enzymatic functions; the NAD+-dependent deacetylase activity 
of Sir2p and the alterations in the linkage or intertwining of DNA strands catalyzed by 
DNA topoisomerase I (Top1p), with no obvious homology shared between the two 
enzymes. Thus, it is not clear why the altered rDNA phenotypes exhibited by top1Δ cells 
are so similar to those observed in sir2Δ mutants. 
In this work, we sought to determine how the loss of Top1p (in top1Δ strains) 
causes alterations in phenotypes involving rDNA. In particular, we focused our attention 
on structural features of Top1p that impact epigenetic aspects of transcriptional 
silencing of ncRNA from cryptic E-pro and C-pro promoters and acetylation of histone 
H4K16 (21; 5), using a strategy of complementing top1Δ strains with a panel of TOP1 
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variant genes, including a series of human/yeast N-terminal top1 chimeras (22). Our 
results indicate a physical interaction of Top1p with Sir2p, and suggest that select 
residues in the N-terminal domain of Top1p functions in the recruitment of Sir2p to the 
rDNA. This property of DNA topoisomerase I was independent of enzyme catalysis and 
illustrates a structural role for Top1p in the epigenetic regulation of rDNA. 
 
RESULTS 
 
Top1p functions in maintaining the extent of H4K16 acetylation and ncRNA 
silencing at the rDNA locus. 
The loss of transcriptional silencing of rDNA repeats, and the increase in histone 
acetylation at the same locus, characterize both sir2∆ and top1∆ mutants in S. 
cerevisiae (6; 7). The histone H4K16 residue is the main target of the Sir2p NAD+-
dependent deacetylase. In sir2Δ mutants, hyperacetylation of this residue has been 
demonstrated to induce a loss of transcriptional silencing, and leads to genome 
instability at rDNA (5). While these molecular features are consistent with the loss of the 
deacetylating activity of Sir2p, the underlying mechanisms involving Top1p in these 
phenotypes are not obvious. To elucidate the role of Top1p in regulating transcriptional 
silencing and histone acetylation at rDNA, we first assessed the extent of H4K16 
acetylation and quantified ncRNA production in a top1Δ strain, which lacks Top1p. 
The relative positions of the 35S gene and the functional elements of the 
intergenic spacer region (IGS) of the 9.1 Kb rDNA unit are diagrammed in Fig. 1. Five 
distinct DNA tracts in the IGS of the rDNA, encompassing the RFB, the cryptic E-pro 
promoter, the 5S promoter, an ARS, and the cryptic C-pro promoter (referred to as 1-5, 
respectively) were analyzed by chromatin immunoprecipitation (ChIP) with an anti-
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H4K16ac antibody (Fig. 2A), in order to measure the extent of histone H4K16 
acetylation. Relative to isogenic wild-type TOP1 cells, top1Δ cells exhibit increased 
levels of H4K16ac throughout the IGS sequences analyzed (see dotted line in Fig. 2A). 
These results are consistent with those previously reported, which indicate an increase 
in histone acetylation at rDNA in a top1Δ strain (19).  
Previous observations demonstrate that rDNA histone acetylation levels correlate 
with increased ncRNA production by RNA polymerase II transcription from the normally 
cryptic E- and C- pro promoters (8; 5). To further characterize the functional 
involvement of Top1p in ncRNA silencing, we measured the three ncRNAs from the IGS 
(detailed in Fig. 1). Total RNA from isogenic top1Δ or wild-type TOP1 strains were 
subjected to semi-quantitative RT-PCR, normalized to UBC6 mRNA expression (23), 
and reported in the histogram of Fig. 2B. A significant (p<0.05) increase in the 
production of the ncRNAs IGS1F and IGS1R from the E-pro promoter was evident in 
top1Δ compared to wild-type cells (dotted line in Fig. 2B). However, in contrast, no 
significant differences in IGS2 ncRNA levels were detected between wild-type and 
top1Δ cells. Taken together, the data reported in Fig. 2 indicate that H4K16 acetylation 
within the IGS of rDNA and ncRNA production from E-pro are, in part, regulated by 
Top1p. 
 
Top1Y727Fp restores wild-type levels of H4K16 acetylation at the rDNA locus. 
Given the different enzymatic activities carried out by Sir2p and Top1p (histone 
deacetylation versus nicking-religation activity on DNA), the remarkable similarity 
among reported phenotypes is not easily explained. In order to shed light on these 
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overlapping phenotypes we first asked: is Top1p catalytic activity required to suppress 
these rDNA phenotypes?  
The active site tyrosine of Top1 (Tyr727) acts as a nucleophile to cleave one 
strand of duplex DNA, and in a transesterification reaction, becomes covalently 
attached to the 3’ phosphoryl end of the nicked DNA strand. Substitution of Phe for 
Tyr727 (in Top1Y727Fp) results in a catalytically inactive protein that is, nevertheless, 
still able to bind duplex DNA (24; 25; 26). In order to evaluate the requirement for Top1p 
catalysis on histone acetylation and ncRNA production, we transformed top1Δ cells with 
a plasmid that constitutively expresses the top1Y727F allele from the TOP1 gene 
promoter (YCptop1Y727F). A similar plasmid expressing wild-type TOP1 served as 
control (YCpTOP1). The absence of Top1p catalytic activity in extracts of 
YCptop1Y727F transformed cells was confirmed in a plasmid DNA relaxation assay 
using negatively supercoiled plasmid DNA (see Fig. 1S).  
The camptothecin (CPT) class of chemotherapeutics specifically targets Top1p, 
by reversibly stabilizing the covalent enzyme-DNA intermediate formed during the 
Top1p catalytic cycle (27; 28; 29).  Thus, CPT treatment increases the stability of 
covalent Top1p-DNA complexes in cells expressing wild-type Top1p, but has no impact 
on cells expressing the catalytically inactive Top1Y727Fp (18). As shown in 
Supplemental Fig. 1S, a strong Top1p cleavage site induced by CPT treatment (30) of 
cells expressing Top1p was not evident in cells expressing the catalytically inactive, and 
therefore CPT resistant, Top1Y727Fp. 
To determine if Top1p catalytic activity was also required to suppress H4K16 
acetylation to the levels observed in wild-type cells, top1Δ cells transformed with 
plasmids YCpTOP1 or YCptop1Y727F were grown in selective media. Wild-type TOP1 
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and top1Δ strains transformed with the empty vector (YCp50) were also analyzed as 
controls. ChIP analyses were then performed as in Fig. 2A.  Fig. 3A depicts the levels of 
H4K16 acetylation detected in the 5 specified regions described in Fig.1, relative to that 
observed in wild-type TOP1 cells (dotted line). In contrast to the decrease in H4K16 
acetylation detected in the absence of Top1p, H4K16 acetylation was restored to wild-
type levels by expression of Top1Y727Fp, across the IGS regions analyzed. Thus, it 
appears that Top1p plays a structural, rather than a catalytic role in the maintenance of 
histone H4K16 acetylation of the IGS of rDNA.  
 
Top1Y727Fp restores IGS1R ncRNA silencing. 
As transcription of ncRNAs from E-pro versus C-pro was selectively de-repressed in 
top1Δ cells (20), we next asked if the extent of IGS1R silencing was also restored by 
Top1Y727F expression. As shown in Fig. 3B, the amount of IGS1R ncRNA expressed 
(relative to UBC6 and normalized to wild-type TOP1 cells) was equivalent in top1∆ 
transformed with TOP1 and top1Y727F expression vectors. Thus, as with H4K16 
deacetylation, these results provide the unexpected observation that DNA 
topoisomerase I catalytic activity is dispensable for ncRNA silencing. 
 
Human TOP1 does not restore H4K16 acetylation or ncRNA silencing at the rDNA 
locus.  
In eukaryotes, the monomeric nuclear DNA topoisomerase I is highly conserved in 
terms of enzyme function and architecture. The human nuclear enzyme (hTop1) shares 
42% identity with yeast Top1p (31) (protein alignment in Supplemental Fig. 5S). The 
conserved core domains of yeast and human Top1p form a protein clamp that 
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completely circumscribes duplex DNA, while a coiled-coil linker domain of variable 
length connects the core domain with the conserved C-terminal domain, which contains 
the active site Tyr residue that cleaves the DNA (32; 33; 34; 35). These conserved core 
and C-terminal domains are ~53 and 62% identical in amino acid sequence, 
respectively. Thus, we asked if a structurally related DNA topoisomerase I, human Top1 
(encoded by hTOP1 cDNA), could also restore wild-type H4K16 acetylation and ncRNA 
silencing yeast top1∆ cells.  
To determine if hTOP1 was able to complement the rDNA phenotypes attendant 
with TOP1 deletion, GAL1-promoted human TOP1 cDNA constructs (YCpGAL1-
hTOP1) (34) or yeast TOP1 vector (YCpGAL1-yTOP1) (34), were introduced into top1Δ 
cells. The YCpGAL1 empty vector, transformed into wild-type TOP1 or top1Δ strains, 
served as controls. Cells were grown in selective medium containing glucose as carbon 
source, and TOP1 expression was induced by shifting the cells into galactose 
containing medium for 6 hours. The activity of the human and yeast enzymes was 
assessed by the formation of CPT-induced covalent Top1p-DNA complexes in the rDNA 
in yeast cells, and in plasmid DNA relaxation assays with crude cell extracts (see 
Supplemental Fig. 2S). We then measured the extent of H4K16 acetylation by ChIP, as 
described in Figs 2 and 3.  As shown in Fig. 4A, the catalytically active human enzyme 
could not suppress the levels of H4K16 acetylation to those observed in wild-type cells 
(dotted line) or in top1∆ cells expressing plasmid-born yeast Top1p (Fig. 4A grey bars). 
Human Top1p was also unable to restore silencing of transcription at the E-pro (Fig. 
4B). RT-PCR quantitation of IGS1R ncRNA production, normalized to UBC6 in wild-type 
TOP1 cells (dotted line), revealed that ncRNA transcription was unchanged in hTOP1 
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expressing cells when compared to top1Δ cells that contain empty vector, while 
silencing was restored by the yeast TOP1 gene.  
Altogether, the data in Fig. 4 demonstrate that hTOP1 failed to complement the 
two molecular phenotypes of top1Δ cells (H4K16 acetylation and ncRNA de-
repression). These findings suggest that DNA topoisomerase I catalytic activity is 
dispensable for ncRNA silencing and histone acetylation control at the rDNA locus, and 
implicate differences in the protein sequence of these homologous enzymes in the 
regulation of rDNA phenotypes.  
 
The N-terminal domain of DNA topoisomerase I impacts rDNA phenotypes. 
Our data suggest that distinct features or residues of Top1p, rather than enzyme 
catalysis, are an important determinant of histone acetylation and silencing at the rDNA 
locus, as the catalytically inactive yeast Top1Y727Fp complements the top1Δ-induced 
rDNA phenotypes, while an active heterologous hTop1 enzyme does not. As shown in 
Supplemental Fig. 5S, the N-terminal domains of yeast and human DNA topoisomerase 
I are poorly conserved, both in terms of size and primary amino acid sequence.  No 
structural information is available for this domain, and it is dispensable for yeast and 
human Top1p catalysis (36). Nevertheless, the N-terminal domain has been shown to 
mediate Top1p-protein interactions (29). Thus we asked: is the yeast N-terminal domain 
required for complementation of top1Δ phenotypes? 
To address this question, we used a chimeric construct (Sc210hTOP1) that 
encodes a fusion protein comprising amino acids 1 to 138 from S. cerevisiae Top1p and 
residues 210 to 765 from the human enzyme, fused at a conserved junction between 
the N-terminal and core domains of these enzymes.  We recently reported that 
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swapping of the N-terminal domains of yeast and human Top1p did not impair the 
specific catalytic activity or CPT sensitivity of the chimeric enzymes (22).  A plasmid that 
expresses the chimeric gene from the galactose-inducible GAL1 promoter (YCpGAL1-
Sc210hTOP1) was used to transform top1Δ cells. Following induction with galactose, 
the activity of the chimeric enzyme was assessed by the formation of CPT-induced 
Top1p-DNA covalent complexes at the rDNA locus in vivo and in a plasmid DNA 
relaxation assays using crude cell extracts (see Supplementary Fig. 3S).  These cells 
were then used in ChIP and RT-PCR analyses, as in Fig. 4.  As shown in Fig. 5A, 
acetylation of H4K16 residues within the IGS was restored to wild-type levels (dotted 
line) in top1Δ cells expressing Sc210hTOP1. Similar results were obtained with top1Δ 
cells transformed with YCpGAL1-yTOP1. The Sc210hTOP1 chimera was also able to 
restore rDNA silencing, as evidenced by the suppression of IGS1R ncRNA expression 
(Fig.5B). These results demonstrate that yeast Top1p N-terminal residues 1-138, within 
the context of the chimeric protein, provide the necessary protein sequences for 
complementation of the rDNA phenotypes.  
 
DNA topoisomerase I contributes to Sir2p recruitment at the rDNA locus. 
As the N-terminal 138 residues of yeast Top1p suffice to enable human Top1p to 
complement the rDNA defects in top1∆ cells (Fig. 5), we hypothesized that this domain 
of Top1p acts in concert with other protein partner(s). Moreover, since top1Δ and sir2Δ 
mutants exhibit a common loss of gene silencing and histone hyperacetylation at the 
same locus, we posited that Top1p recruits Sir2p to the rDNA. To begin addressing this 
model, ChIP experiments were performed with Sir2p antibodies to analyze regions 
where Sir2p has previously been reported to bind (35S RNA promoter and RFB, regions 
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1 and 5 in Fig. 1) (37). As seen in Fig. 6, Sir2p was enriched at these regions of the 
rDNA repeats in wild-type TOP1 cells: a two-fold decrease in Sir2p bound to both the 
35S RNA promoter and RFB was observed in top1∆ cells compared to an isogenic wild-
type strain (black bars compared to the dotted line in Fig. 6). However, the effect of 
top1∆ on Sir2p binding to chromatin appears to be selective for the rDNA locus, as no 
decrease was evident at other Sir2p binding sites - telomeric sequences of 
chromosome IV and the HM-L locus (see Supplementary Fig. 4S). However, while Sir2p 
dependent-silencing at the HML alpha locus was maintained (not shown), the loss of 
telomeric region silencing in top1∆ cells has previously been reported (38). These 
distinct effects on Sir2p chromatin binding and transcriptional silencing indicate that a 
global loss of Sir2p activity is not induced by deletion of TOP1.  
In Fig. 6A, wild-type levels of Sir2p in rDNA chromatin were restored in top1Δ 
cells that constitutively express plasmid-encoded yeast Top1p or Top1Y727Fp. 
Conversely, in top1Δ cells transformed with YCpGAL1-hTOP1, the amount of Sir2p 
remained the same as that observed in top1Δ cells (Fig. 6B). Thus, in agreement with 
silencing and acetylation phenotypes assessed in Figs. 2-5, the catalytically inactive 
Top1Y727Fp sufficed to restore Sir2p binding to rDNA, while the active human enzyme 
did not. Given that the Sc210hTop1 chimera also complemented top1∆-induced defects 
in rDNA silencing and histone acetylation, we next investigated its ability to restore 
Sir2p binding at rDNA. Indeed, as shown in Fig. 6C, Sir2p levels were also restored in 
top1∆ cells expressing the yeast/human Top1p chimera. In this context, it is worth 
noting that it was not possible to investigate a possible role of the N-terminal 
polypeptide alone in recruiting Sir2p to the rDNA in the nucleolus, since it has been 
reported in human cells that the N-terminal domain (as a single polypeptide) 
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translocates from the nucleolus to the nucleoplasm (39), thus preventing any nucleolar -
specific interactions.  
 
A defined N-terminal region of yeast DNA topoisomerase I rescues ncRNA 
silencing. 
To further characterize the specific N-terminal residues of yeast Top1 required to 
restore rDNA silencing and histone deacetylation, an additional series of previously 
described N-terminal yeast-human and human-yeast Top1p chimeras were analyzed: 
Sc∆201hTOP1; Sc192hTOP1; h120ScTOP1; h138ScTOP1 (Fig. 7A) (22). YCpGAL1 
plasmids containing the chimera gene constructs were transformed into top1Δ cells, and 
IGS1R ncRNA expression was evaluated by RT-PCR. As shown in Fig. 7B, expression 
of only one additional chimera, Sc∆201hTOP1, was able to restore ncRNA silencing. 
Thus, of the five chimeras examined, only those comprising yeast residues around 
amino acids 115-125 (in Sc210h and Sc∆201h, but not Sc192h) were active in 
complementing top1∆-mediated rDNA dysregulation.  As shown in Fig. 7A, the common 
element shared by wild-type yeast Top1p and the two chimeras capable of restoring 
ncRNA silencing is a continuous stretch of 6 glutamic acidic residues (highlighted 
yellow). In the case of Sc∆201h, the generation of this six residue acidic patch was a 
fortuitous consequence of a PCR-induced error in the generation of the chimera (22).  
 
DNA topoisomerase I and Sir2p physically interact 
Given the genetic interaction of yeast Top1p and Sir2p at the rDNA, we next asked if 
the observed phenotypes result from the physical interaction of these proteins.  Protein 
extracts of isogenic wild-type SIR2,top1∆ or sir2∆,top1∆ yeast cells expressing the 
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indicated yeast, human and chimeric Top1 proteins were subjected to 
immunoprecipitation (IP) with a bead bound antibody that recognizes the N-terminal 
FLAG epitope engineered into each TOP1 construct. The bead bound proteins were 
then immunoblotted with anti-FLAG or anti-Sir2 antibodies to assess co-
immunoprecipitation of Sir2p with Top1p. A yeast Topo70 construct was also included in 
this analysis, as this ScTopo70p lacks the first 102 residues of yeast Top1p, yet still 
contains the stretch of acidic residues found in the Sc∆201h and Sc210h chimeras (see 
Fig. 7A).  As seen in Fig. 8, Sir2p was detected following immunoprecipitation in the 
yeast Top1p, ScTopo70p and chimera samples, with the strongest signal detected with 
ScTopo70p expressing cells. Conversely, in the IP performed with extracts from cells 
expressing hTop1p, Sir2p was not detected. Thus, Sir2p appeared to physically interact 
with all proteins that contain yeast Top1p residues derived from sequences that span 
the chimera junctions; yet, Sir2p did not interact with human Top1p. In this regard it is 
worth noting that all of the Top1 proteins examined, with the exception of human Top1p, 
contain longer stretches of acidic residues or more repeats of shorter patches of acidic 
residues than those contained in the human enzyme (Fig. 7A). These elements may 
suffice to mediate Sir2p binding to Top1p; however, the functional consequence of this 
interaction on restoring ncRNA silencing is only evident with yeast Top1p, and the 
Sc∆201h and Sc210h chimeras, which uniquely share a longer acidic patch (EEEEEE). 
 
 
DISCUSSION 
 
RNA polymerase II transcriptional silencing at the rDNA locus was first described in 
1997 (6; 7), and different gene products have been reported to contribute to this 
phenomenon (40). The SIR2 gene product appears to comprise the main regulator of 
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silencing within this locus, and the histone deacetylase activity of Sir2p is crucial for this 
function (41). The TOP1 gene has also been implicated in rDNA silencing (6; 7). 
However, the molecular basis of Top1p-mediated regulation of rDNA silencing was an 
enigma, as the DNA nicking-religation activity of DNA topoisomerase I did not readily 
suggest involvement in this process.  
In order to understand the role of Top1p in RNA polymerase II silencing in rDNA 
repeats, we first discerned that the enzymatic activity of Top1p was dispensable for 
rDNA silencing. However, the physical presence of the Top1 protein was essential.  In 
particular, the top1Δ mutant defects in ncRNA production and histone acetylation were 
complemented by plasmid encoded wild-type yeast TOP1, as well as the catalytically 
inactive yeast top1Y727F mutant. The characteristic hyper-production of ncRNAs and 
histone hyperacetylation at the IGS region, evident in top1Δ cells, were suppressed in 
both cases, demonstrating that presence of Top1 protein alone sufficed to regulate 
these two phenotypes. Since Top1Y727Fp binds DNA with the same affinity as wild-
type yeast Top1p (26; 42), these findings implicate specific protein interactions with 
Top1p in Pol II silencing at the rDNA locus.  
We further demonstrated that human Top1p, which shares a common reaction 
mechanism, enzyme architecture, and 42% identity with the yeast enzyme (31), was 
unable to restore rDNA silencing or suppress H4K16 acetylation in yeast top1Δ cells. 
These findings suggest that specific sequences and/or structural elements unique to 
yeast Top1p are required to restore the rDNA defects induced by deletion of the TOP1 
gene. A structural role for human Top1 in Pol II transcriptional regulation has also been 
reported: the catalytic activity of the human enzyme was dispensable for Top1 function 
in the repression and activation of gene transcription in mammalian cells, yet the yeast 
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Top1 protein was not able to complement the loss of human Top1 (43; 44).  Previous 
reports further suggest that the DNA topoisomerase I N-terminal domain mediates 
interactions with different protein partners (36; 45). Indeed, using a series of 
yeast/human chimeras involving reciprocal swaps of the poorly conserved N-terminal 
domains, our findings demonstrate a pivotal role for select yeast DNA topoisomerase I 
N-terminal residues in maintaining the silencing and the epigenetic status of the rDNA.  
Together these data illustrate that: i) Top1p contributes to Sir2p recruitment to rDNA 
chromatin, but not other loci; ii) the recruitment of Sir2p to the rDNA does not depend on 
Top1p catalytic activity; and iii) specific N-terminal residues of the yeast enzyme are 
required for Sir2p recruitment.  
The latter point in particular is intriguing and worthy of further consideration. With 
Sc210hTop1, which comprises the first 138 residues of yeast Top1 fused to amino acid 
residues 210-765 of human Top1, the catalytic activity and camptothecin sensitivity of 
the fusion protein mirrored that of wild-type human Top1 (22). In the current studies, 
Sc210hTop1 expressing cells behaved like wild-type yeast TOP1, strains, 
demonstrating that the regulation of rDNA silencing and IGS histone H4K16 acetylation 
is mostly due to the N-terminal sequences of yeast Top1, and correlates with the 
physical recruitment of Sir2p to the rDNA.  These results were not observed with human 
Top1.  
Nevertheless, our data further suggest that a physical interaction of Top1p with 
Sir2p alone does not suffice to complement the rDNA defects of top1∆ cells.  First, all of 
the yeast/human Top1 chimeras examined (Sc210hTOP1; Sc∆201hTOP1; 
Sc192hTOP1; h120ScTOP1; and h138ScTOP1), as well as ScTopo70 (which lacks the 
first 102 residues of yeast Top1), were capable of associating with Sir2p in 
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immunoprecipitation experiments, albeit to varying levels (Fig. 8).  Yet, only wild-type 
yeast Top1, ScTopo70, and two chimeras, Sc210hTop1p and Sc∆201hTop1p sufficed 
to restore wild-type levels of ncRNA silencing and IGS H4K16 acetylation.  In this 
context, the deletion of 8 residues (EEEDKKAK) in Sc∆201hTop1p, an unintended error 
introduced in the generation of this chimera (22), nevertheless provided a critical insight 
into the functional elements within the N-terminal domain of yeast Top1p.  As shown in 
Fig. 7A, the unique feature shared by the four constructs capable of restoring rDNA 
silencing and epigenetic regulation by Sir2p, is an R residue followed by a stretch of 
seven acidic residues EEEEEED and KKAK in yeast Top1p, ScTopo70p and 
Sc210hTop1p, or R followed by six acidic residues EEEEEE and QKWK in 
Sc∆201hTop1. In contrast, Sc192hTop1p, which did not complement the rDNA of top1∆ 
cells, has R followed by a slightly shorter stretch of five acidic residues EEEEE and 
KKKPKK (see Fig. 7A).  Unfortunately, the corresponding stretch of residues in human 
Top1p (EPDNKKKPKK) are not resolved in the crystal structures of human Topo70 (33, 
35), and acidic/basic patches may not be expected to have well-defined secondary 
structure in solution. Nevertheless, these residues would be expected to reside on the 
surface of the protein. Moreover, if arrayed in an alpha-helix, the shorter stretch of 
acidic residues in Sc192hTop1p (REEEEEKKK) would produce a shift in registry of 
charge, such that one helical face would be net-positive. In contrast, with the longer 
acidic stretches in Sc∆201hTop1p (REEEEEEQK) or Top1p, ScTopo70p and 
Sc210hTop1p (REEEEEEDK), all helical faces would be net-negative. These 
differences could have profound effects on protein interactions with Top1p.  An 
additional possibility is that the presence of a Pro within the adjoining human stretch of 
Lys residues in Sc192hTop1p (KKKPKK) may alter the structure of the yeast KKAK 
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residues to impair critical protein-protein interactions. Although these considerations 
await additional structural determinations of yeast and human Top1p N-terminal 
domains, our findings nevertheless lead to the following implications: a role for the N-
terminal 138 residues of yeast Top1p in the physical binding of Sir2p; with residues in 
115-125 of yeast Top1 required for the functional interactions necessary for 
complementation of top1∆-induced rDNA defects.  These data further establish the role 
of DNA topoisomerase I in the epigenetic regulation of rDNA, independent of enzyme 
catalysis.  
 
MATERIALS AND METHODS 
Yeast strains used in these studies were two pairs of isogenic strains: W303-1a (MATa, 
ade2-1, ura3-1, his3-11,15, trp1-1, leu2-3,112, can1-100), wild-type for TOP1 and 
AMR51 (W303-1a; top1∆::LEU2); and EKY2 (MATa, ura3-52, his3∆200, leu2∆1, 
trp1∆63, top1∆::HIS3) (46) and MHY16 (EKY2, sir2∆::TRP1). Yeast cells were grown 
and manipulated according to standard protocols (47). Culture media were YPD 
(complete media), and YNB without URA/ 2% glucose or YNB without URA/ 2% 
galactose (minimal media).  
Plasmids that constitutively express yeast TOP1 or top1Y727F from the yeast 
TOP1 promoter (YCpTOP1 and YCptop1Y727F, respectively) have been described 
(18).  Galactose-inducible expression of wild-type yeast and human Top1p, yeast 
Topo70p, and a series of yeast/human and human/yeast N-terminal chimeric enzymes, 
was achieved with plasmids YCpGAL1yTOP1, YCpGAL1hTOP1, YCpGAL1yTopo70, 
YCpGAL1Sc192hTOP1, YCpGAL1Sc∆201hTOP1, YCpGAL1Sc210hTOP1, 
YCpGAL1h120ScTOP1, and YCpGAL1h138ScTOP1 as described (22). The Sc and h 
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designations indicate the order of yeast and human TOP1 sequences, respectively, 
while the number refers to the first amino acid residue encoded by the 3’ chimera 
partner. For instance, in Sc210hTOP1, the junction between the N-terminal yeast Top1p 
sequences and the C-terminal human Top1p sequences begins with human residue 
210. The construction of these chimeras was previously reported (22) and a diagram of 
the sequences flanking the chimeric junctions is provided in Fig. 7A. In all cases, the 
constructs were engineered with an N-terminal FLAG epitope tag.  Oligonucleotides 
sequences are provided in Supplemental Table T1. 
 
RT-PCR analysis   
RNA from logarithmically growing cultures was isolated as previously described (48). 
0.75 g of DNAse I treated RNA (30 min. at 37°C) were subjected to cDNA synthesis 
with BioscriptTM Reverse Transcriptase (Bioline reagents Ltd, United Kingdom) for 60 
min a 42°C. UBC6 and IGS1R ncRNA were reverse transcribed using an oligo dT 
primer. IGS1F ncRNA was reverse transcribed with an IGS1Fr specific primer 
(Supplemental Table T1). IGS2 ncRNA was reverse transcribed using random 
hexamers. The reverse transcriptase reaction was stopped by heat inactivation of the 
enzyme at 85°C for 5 min. The resulting cDNA (35 ng) was PCR amplified, using the 
forward and reverse primers for IGS1R, IGS1F, IGS2, UBC6 (Supplemental Table T1), 
under the following conditions: denaturation at 95°c for 30 sec, annealing at 55°C for 30 
sec and elongation at 68°C for 30 sec with 16 cycles for UBC6 and 24 cycles for 
ncRNAs. Taq polymerase was from Eppendorf (Hamburg, Germany). [α-32P]dATP 
(Amersham, GE Healthcare) was added to the reaction mixture (0.04μCi/μl). Template 
titration for each sample was performed in order to evaluate the linear range of the 
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amplification. The amplified fragments were separated on a 6% acrylamide gel and 
quantification was performed using ImageJ 1.42q.  ncRNA bands intensity was 
normalized to the UBC6 value. Average (with standard deviations) refers to at least 
three independent ratios: [mutant or transformed strain ncRNA/ UBC6 RNA]/[wild-type 
ncRNA/UBC6 RNA]. p-values were obtained using Student’s t-test. 
 
Chromatin Immunoprecipitation (ChIP) 
Exponential phase cultures (200 ml) were cross linked with 1% formaldehyde at room 
temperature for 15min (for acH4K16 or total H4 immunoprecipitation) or 20 min (for 
Sir2p immunoprecipitation), and then incubated with 330mM glycine for 10min, to 
quench the formaldehyde reaction. Cells were then processed for ChIP as described 
(26). Cells were washed with 140mM NaCl, 2.5mM KCl, 8.1mM Na2HPO4, 1.5mM NaCl, 
1mM EDTA, 1%TritonX-100, 0.1% sodium deoxycholate, 0.1%SDS, protease inhibitors 
and lysed with glass beads, by vigorous shaking for 1h at 4°C. Chromatin extracts were 
recovered and subjected to sonication four times for 20 sec at an amplitude needed to 
obtain an average DNA fragment size of 500 to 1000 bp. Equal amounts of chromatin 
extract (350μg of Bradford quantified proteins) were treated as Input (i.e. genomic non-
immunoprecipitated DNA) or as IP (Immunoprecipitated DNA). IP samples were 
incubated at 4°C overnight, at the final concentration of 140mM NaCl, with 100μg of 
BSA and 2.5μg of antibodies against Sir2p, histone H4 terminal tail, or acetylated 
H4K16. Chromatin antibody complexes were isolated with protein A Sepharose beads 
(Amersham, GE Healthcare) for 1.5h at 4°C. Beads were then washed with lysis buffer 
containing increasing amounts of NaCl, deoxycholate buffer (10mM Tris- HCl pH 8, 
1mM EDTA). Immunoprecipitated chromatin was then eluted by incubation with 100μl of 
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50mM Tris- HCl pH 8, 10mM EDTA, 1%SDS at 65°C for 15min. All samples (IP and 
Input) were then incubated at 65°C overnight to reverse the crosslinking, treated with 
0.5 μg/ml proteinase K and 0.25 μg/ml RNase A. The recovered DNA was resuspended 
in 200μl for Input samples and in 50μl for IP samples. 1μl from Input and 3μl from IP 
were used as template for PCR in order to obtain comparable autoradiographic signals. 
PCR was performed under the following conditions: denaturation at 95°C for 30 sec, 
annealing at 55°C for 30 sec, and elongation at 68°C for 30 sec, with 17 cycles for IGS 
rDNA sequences and 27 cycles for ACTIN. α-32P dATP was added to the reaction 
mixture (0.04μCi/μl). Multiplex PCR reactions were performed between: 
(ENH/ARS/ACT1); (E-pro/C-pro/ACT1); (5S/ACT1). The amplified fragments were 
separated on a 6% acrylamide gels and quantification was performed using ImageJ 
1.42q.  
 
The fold enrichment values, obtained using antibodies, were calculated as follows:  
[rDNA(IP)/ACT1(IP)]/ [rDNA(Input)/ACT1(Input)]. Final values relative to acH4K16 were 
obtained after normalization to total H4 values. After this calculation, the isogenic wild-
type TOP1 strain values were normalized to 1, obtaining the enrichment amount shown 
for the different strains or conditions. The graphs show the mean and standard deviation 
of relative enrichments calculated from three different PCR experiments. p-values were 
obtained using Student’s t-test. 
 
Co-immunoprecipitations 
Galactose-induced cultures of EKY2 (SIR2) or MHY16 (sir2∆) cells expressing N-
terminal FLAG-tagged Top1p were lysed with prechilled (-20˚C) glass beads in 50 mM 
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Tris, pH 7.4, 1 mM EDTA, 1 mM EGTA, 200 mM KCl, and 10% glycerol, supplemented 
with complete protease inhibitors (Roche). Triton X-100 was added to a final 
concentration of 1%. Aliquots were incubated with anti-FLAG agarose beads (Sigma) 
and rotated end-over-end for 2 hours at 4°C. The samples were washed five times with 
50 mM Tris, pH7.4, 200 mM KCl and protease inhibitors. SDS sample buffer lacking 
DTT was added to each sample and the proteins were resolved by SDS-PAGE and 
visualized by immunoblotting with antibodies specific for the FLAG epitope tag onTop1p 
or Sir2p. 
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Figure Legends 
 
Figure 1. Schematic map of the ribosomal genes in S. cerevisiae. Horizontal grey 
arrows represent the 35S RNA pol I and 5 S RNA pol III transcripts. Black arrows 
represent the ncRNA Pol II transcripts, intergenic spacer IGS1F and IGS1R from E-pro, 
and IGS2 from C-pro. Filled boxes indicate 35S and 5S coding units. Ellipses refer to 
positioned nucleosomes. The boxed areas in the lower part of the figure delineate the 
relative position of DNA sequences used for ChIP experiments, while the arrows 
indicate the orientation of oligonucleotides used for RT-PCR or primer extension. 
 
Figure 2. top1∆ induces increased H4K16 acetylation and the loss of E-pro 
promoter silencing within the IGS of rDNA.  
A: ChIP analysis of H4K16 acetylation at rDNA. Extracts from crosslinked wild-type and 
top1Δ cells were immunoprecipitated with an anti -H4K16 or anti -H4 antibody. The 
DNA recovered from the immunoprecipitated chromatin was amplified to analyze 5 
rDNA regions specified in Figure 1. H4K16 acetylation data were normalized to total H4 
and then to values obtained with wild-type cells (wild-type=1, dotted line). Values with 
standard deviations from three independent experiments are reported. * p <0.05 and  ** 
p <0.01.  
B: RT-PCR analysis of ncRNA expression. RNA from wild-type and top1Δ strains was 
analyzed. The levels of ncRNA transcripts were normalized to UBC6 mRNA and then to 
values obtained from wild-type cells (wild-type=1, dotted line). In the histogram, values 
with standard deviations from three independent experiments are reported. ** p <0,01.  
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Figure 3. Enzymatic activity of Top1 is dispensable for H4K16 acetylation and 
ncRNA silencing at IGS.  
A: H4K16 acetylation at Enh, E-pro, 5S, ARS, C-pro (regions 1,2,3,4,5 in Fig. 1) were 
detected by ChIP as in Fig 2. Data from top1Δ cells are shown as black bars, from 
top1Δ cells expressing yTOP1 as grey bars, and from top1Δ cells expressing 
ytop1Y727F (a catalytically inactive mutant of yTOP1) as white bars. Normalized data 
obtained from wild-type TOP1 cells = 1 (dotted line). Values with standard deviations 
from three independent experiments are reported. * p< 0.05  ** p <0.01.  
B: IGS1R ncRNA expression assessed by RT-PCR in the same strains as in A, and as 
described in the legend to Fig. 2. Normalized data from wild-type TOP1 cells = 1 (dotted 
line). Values with standard deviations from three independent experiments are reported. 
* p <0.05  ** p <0.01 
 
Figure 4. AcH4K16 and silencing of IGS1R are similar in top1Δ mutants and top1Δ 
cells expressing human TOP1.  
A: ChIP analysis of H4K16 acetylation, as in Fig. 2 legend. Data from top1Δ cells in 
black bars, from top1Δ cells expressing yTOP1 from the GAL1 promoter in grey bars, 
and from top1Δ cells expressing hTOP1 from the GAL1 promoter in white bars. 
Normalized data from wild-type TOP1 cells =1, dotted line. Values with standard 
deviations from three independent experiments are reported. * p< 0.05   ** p <0.01.  
B: IGS1R ncRNA levels produced by top1∆ yeast cells expressing yeast or human 
TOP1 (as in A) were assessed by RT-PCR as described in Fig. 2 legend.  Normalized 
wild-type TOP1 strain data =1, dotted line, Values with standard deviations from three 
independent experiments are reported. * p <0.05  ** p <0.01. 
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Figure 5. Sc210htop1 complements top1Δ-induced alterations in H4K16 
acetylation and IGS1R ncRNA production.  
A: ChIP analysis of acetylated H4K16, as in Fig. 2, was performed in wild-type TOP1 
cells (dotted line), top1Δ cells (black bars), top1Δ cells expressing yTOP1 (grey bars), 
and top1Δ expressing the yeast/human chimera Sc210htop1 (white bars). Values with 
standard deviations from three independent experiments are reported. *P<0.05,** 
P<0.01.  
B: IGS1R ncRNA transcription detected by RT-PCR in the same strains as in A, as 
described in Fig. 2 legend. All data were normalized to UBC6 expression, then to data 
obtained with wild-type TOP1 cells (dotted line); values with standard deviations from 
three independent experiments are reported. * p <0.05, ** p <0.01 
 
Figure 6. Sir2p enrichment at rDNA is influenced by the yeast N-terminal domain 
of Top1p, but not Top1p enzymatic activity.  
ChIP assays of acetylated H4K16, performed in extracts of top1Δ cells (black bars), or 
top1Δ cells expressing plasmid-encoded yTOP1 (dark grey bars), ytop1Y727F (light 
grey bars), hTOP1 (dot bars) or Sc210htop1 (white bars), subjected to 
immunoprecipitation with an anti-Sir2p antibody. DNA recovered from chromatin was 
PCR amplified using oligonucleotides annealing to Enhancer (region 1) or C-pro (region 
5) sequences as diagrammed in Fig. 1. All values are normalized to wild-type TOP1 
cells (dotted line). Values with standard deviations from three independent experiments 
are reported. *p<0.05 and ** p<0.01.  
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Figure 7. IGS1R ncRNA transcription in yeast cells expressing chimera TOP1 
genes Sc201hTOP1, Sc192hTOP1, h138ScTOP1, h120ScTOP1. 
A: Alignment of amino acid residues spanning the chimera junctions of yeast (pink 
residues) and human (black residues) Top1p, as described in (22). Color coded 
numbers refer to residue number, while numbered allele designations indicate the first 
residue of the C-terminal yeast (pink) or human (black) Top1p sequences contained in 
the chimeric enzymes.  In Sc∆201h, sequences encoding 8 residues of yeast Top1p, 
just N-terminal to the chimera junction, were deleted during plasmid construction 
(indicated by a yellow line). ScTopo70p lacks the first 102 residues and corresponds to 
human Topo70 constructs that lack the first 174 amino acid residues of human Top1p 
(35).  Stretches of 6 or more acidic residues shared by ScTop1, ScTopo70, Sc∆201h 
and Sc210h are highlighted in yellow, while shorted patches of Glu residues in the all 
constructs are in blue. 
B: As in Fig. 2 legend, ncRNA expression in top1∆ strains expressing the indicated 
chimera or Top1 protein, was detected by RT-PCR, and normalized to UBC6 and data 
from wild-type TOP1 cells (dotted line). Values with standard deviations from three 
independent experiments are reported. *p<0,05; **p>0,01.  
 
Figure 8. Yeast Top1p, but not human Top1p, physically interacts with Sir2p. Co-
immunoprecipitation analyses were performed with extracts of top1Δ,SIR2 (left panel) or 
top1Δ,sir2Δ (right panel) cells expressing the indicated yeast, human and chimera Top1 
proteins.  Lysates were incubated with beads linked to anti-FLAG antibodies. The 
resulting immunoprecipitates, and input lysate samples were then subjected to 
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immunoblot analysis with antibodies specific for the FLAG-tagged Top1 proteins or 
Sir2p. GAPDH served as loading control for lysates.   
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